Search results for "Essential"

showing 10 items of 812 documents

A-6G polymorphism of the angiotensinogen gene and body weight changes in essential hypertension: a prospective study

2001

medicine.medical_specialtybusiness.industryOverweightBody weightEssential hypertensionmedicine.diseaselaw.inventionEndocrinologylawInternal medicineGenotypeInternal MedicinemedicineAngiotensinogen genemedicine.symptomProspective cohort studybusinessWeight gainPolymerase chain reactionAmerican Journal of Hypertension
researchProduct

Effects of Antihypertensive Treatment on Peripheral Flow of the Lower Limbs

1984

The clinical pattern determined in subjects that undergo a high and prolonged pressure regime is defined as “hypertensive disease”.

medicine.medical_specialtybusiness.industryResistant hypertensionEssential hypertensionmedicine.diseaseIntermittent claudicationPeripheralHypertensive diseaseText miningInternal medicineCardiologyMedicinemedicine.symptombusiness
researchProduct

Different Morning Blood Pressure Increases are Associated to a Diverse Microvascular Damage

2007

medicine.medical_specialtybusiness.industryStiffness indexRenal functionEssential hypertensionmedicine.diseasemedicine.anatomical_structurePharmacotherapyInternal medicineAmbulatoryInternal MedicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessArteryHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Hemodynamic Changes in Patients with Essential Hypertension after Therapy with Muzolimine

1987

Muzolimine is a new nonsulfonamide diuretic belonging to the pyrazolinone group (1).It is a potent high-ceiling diuretic agent like furosemide and bumetanide with long duration of action like thiazides (1, 2).

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCardiac indexFurosemideHemodynamicsEssential hypertensionmedicine.diseasechemistry.chemical_compoundchemistryInternal medicinemedicineCardiologyMuzolimineIn patientDiureticbusinessBumetanidemedicine.drug
researchProduct

Orthostatism modifies insulin-like growth factor 1 and insulin plasma levels in essential hypertension.

1999

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentInsulinPlasma levelsmedicine.diseaseEssential hypertensionInsulin-like growth factorEndocrinologyInternal medicinePathophysiology of hypertensionInternal MedicinemedicinebusinessAmerican Journal of Hypertension
researchProduct

Research on neuropsychiatric symptoms in patients with essential tremor and Parkinson’s disease in Latvian population

2016

medicine.medical_specialtyeducation.field_of_studyParkinson's diseaseEssential tremorbusiness.industryPopulationLatvianmedicine.diseaselanguage.human_languagePhysical medicine and rehabilitationNeurologylanguageMedicineIn patientNeurology (clinical)Geriatrics and GerontologybusinessPsychiatryeducationParkinsonism & Related Disorders
researchProduct

Treatment of patients with essential hypertension and microalbuminuria.

1998

There has been increasing interest in the question of whether microalbuminuria can be used in the risk stratification of patients with essential hypertension. A cluster of cardiovascular and/or renal risk factors may be associated with microalbuminuria in hypertension. Despite this, prospective data about the potential role of microalbuminuria as a prognostic marker of cardiovascular and/or renal risk have been sparse and inconclusive until now. Blood pressure values have been considered the most important determinant of microalbuminuria in essential hypertension; however, hyperinsulinaemia--a metabolic component-was noted to be present in conjunction with high blood pressure. Furthermore, …

medicine.medical_specialtyendocrine system diseasesbusiness.industrynutritional and metabolic diseasesProspective dataurologic and male genital diseasesmedicine.diseaseDisease clusterEssential hypertensionfemale genital diseases and pregnancy complicationsSurgeryPharmacotherapyFelodipineInternal medicineRisk stratificationHypertensionmedicineDoxazosinAlbuminuriaHumansPharmacology (medical)MicroalbuminuriabusinessAntihypertensive Agentsmedicine.drugDrugs
researchProduct

Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertension

1995

In a group of subjects with essential hypertension platelets were studied in resting conditions: platelet membrane fluidity was measured with the fluorescent probe 1.4-(trimethylamino)-phenyl-4-phenylhexatriene (TMA-DPH), platelet membrane cholesterol/phospholipid ratio was evaluated separating the membrane lipids with column chromatography, and platelet membrane individual phospholipids were determined using two-dimensional thin-layer chromatography. From the obtained results, it is evident that platelet membrane fluidity does not differentiate normals from hypertensives; platelet membrane cholesterol/phospholipid ratio is increased in hypertensives, while of the platelet membrane individu…

medicine.medical_specialtyfood.ingredientCholesterolbusiness.industryMembrane lipidsEssential hypertensionmedicine.diseaseLecithinchemistry.chemical_compoundfoodEndocrinologyMembranechemistryBiochemistryPhosphatidylcholineInternal medicineInternal MedicinemedicineMembrane fluiditylipids (amino acids peptides and proteins)PlateletbusinessAmerican Journal of Hypertension
researchProduct

Bone Marrow Biopsy Revision According to WHO Criteria in 272 Patients of the Registro Italiano Trombocitemia (RIT): Preliminary Report On Clinical an…

2009

Abstract Abstract 4974 Background The bone marrow trephine biopsy (BMB) has a crucial role for the diagnosis of essential thrombocythemia (ET), both according to the PVSG and the WHO criteria. The WHO 2001 criteria enhanced the role of BMB also by distinguishing the true-ET (ET) from the prefibrotic and the early fibrotic chronic idiopathic myelofibrosis. The WHO 2008 criteria, in the JAK2 era, confirmed the diagnostic and prognostic relevance of the histopathological features in ET as well as in the other Ph-neg myeloproliferative neoplasms (MPN). Otherwise, only few validated data are presently available, and the reproducibility in the evaluation of some morphological details is still con…

medicine.medical_specialtymedicine.diagnostic_testEssential thrombocythemiabusiness.industryPipobromanImmunologyCell BiologyHematologyAnagrelidemedicine.diseaseBiochemistryGastroenterologyGroup BSurgeryPolycythemia veraInternal medicineBiopsymedicinebusinessMyelofibrosisBusulfanmedicine.drugBlood
researchProduct

Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression?

2005

PURPOSE OF REVIEW The success of an antihypertensive treatment is difficult to estimate by the extent of blood pressure reduction alone. Above and beyond blood pressure values in an individual patient, it is necessary to monitor the impact of antihypertensive treatment on the development or regression of hypertension-induced early end-organ damage. The intermediate objectives or surrogate endpoints may provide additional valuable information about the level of success of a given therapy in a particular patient. Moreover, monitoring intermediate objectives may provide scientific evidence for delineating the best antihypertensive treatment. RECENT FINDINGS The importance of assessing left ven…

medicine.medical_specialtymedicine.medical_treatmentBlood PressureLeft ventricular hypertrophyEssential hypertensionInternal medicineDiabetes mellitusDiabetes MellitusInternal MedicinemedicineAlbuminuriaHumansAntihypertensive AgentsReduction (orthopedic surgery)business.industrySurrogate endpointmedicine.diseaseCarotid ArteriesBlood pressureNephrologyHypertensionCardiologyAortic pressureHypertrophy Left VentricularMicroalbuminuriabusinessCurrent Opinion in Nephrology & Hypertension
researchProduct